Six Experts Map the Future of Rare Metabolic Disease Research
Six leading researchers outline the opportunities, challenges and emerging priorities for advancing research and therapy development in rare metabolic diseases.
Six leading researchers outline the opportunities, challenges and emerging priorities for advancing research and therapy development in rare metabolic diseases.
Critical Path Institute's Translational Therapeutics Accelerator has awarded nearly $1.7 million across five BRIDGe grants to advance therapies for neuropathic ...
The Journal of Pharmaceutical Investigation has been indexed in the Science Citation Index Expanded since 2021 and achieved a 2022 ...
A combined Mendelian randomization and colocalization analysis of large genetic datasets has identified candidate drug targets for depression, anxiety, schizophrenia, ...
A new single-molecule technique called Iterative Mapping enables large-scale quantification of intact tau proteoforms in control samples, disease models, and ...
Researchers propose reframing drug development as an iterative, data-centric learning system in which single-cell readouts from human immunotherapy responses continuously ...
In a groundbreaking advancement in synthetic chemistry, researchers from Japan have unveiled a novel method for synthesizing inaoside A, a ...
For decades, scientists have grappled with the intricacies surrounding filopodia, the slender, finger-like protrusions extending from cell membranes and playing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine